New User:

Forgot your password?

Stock Market & Financial Investment News

Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | all recent news | >>
June 26, 2015
12:58 EDTMUOn The Fly: Top stock stories at midday
Stocks on Wall Street were mixed at midday, with Nike's (NKE) post-earnings rise providing a boost to the Dow and Micron's (MU) slide dragging on the tech-heavy Nasdaq. ECONOMIC EVENTS: In the U.S., the University of Michigan consumer sentiment reading rebounded to 96.1 in the final June report from the preliminary 94.6 reading. That revised figure topped the expected reading of 95. In Europe, the ECB left the level of emergency cash available to Greek banks unchanged again Friday as deposit outflows have slowed, according to people familiar with the matter reporting to Bloomberg. Greek leaders are scheduled to hold talks Saturday with the Eurogroup in what may be the nation's last chance for a deal ahead of the expiration of the current bailout agreement on June 30. In China, stocks plunged by the most in five months as the Shanghai Composite Index fell 7.4%, with market watchers citing margin worries and concerns that the PBOC will be less likely to undertake further rate cuts. COMPANY NEWS: Shares of Nike advanced 4% after the athletic apparel and sneaker maker reported fourth quarter results that handily beat expectations. Several firms raised their respective price targets on the stock following the company's Q4 report, including Goldman, which reiterated its Conviction Buy rating on Nike and raised its price target to $131 from $121. Finish Line (FINL), an athletic shoe and apparel retailer that sells Nike products, rose 5% after its own first quarter results also topped the consensus forecast. MAJOR MOVERS: Among the notable gainers was OPKO Health (OPK), which rose nearly 4% after the company announced the decision of the National Comprehensive Cancer Network to include 4Kscore as a recommended test in the 2015 NCCN Guidelines for Prostate Cancer Early Detection. Additionally, CEO Phillip Frost disclosed in regulatory filings that he'd acquired over 64,000 shares of the company stock in the last two days. Also higher was Kforce (KFRC), which gained 7% after SunTrust upgraded the stock to Buy and raised its price target to $27 from $24, noting that the firm's private IT staffing poll suggests margin assumptions may prove conservative. Among the noteworthy losers was Micron, which sunk about 19% after the flash memory maker reported weaker than expected results last night and provided lower than expected Q4 revenue guidance. Also lower were shares of coal miner Peabody (BTU), which fell 7% after Moody's downgraded the company's credit rating to reflect the firm's expectation for the deterioration in the company's credit metrics to be more precipitous than it had previously thought due to the ongoing decline in the seaborne metallurgical coal markets. INDEXES: Near midday, the Dow was up 53.70, or 0.3%, to 17,944.06, the Nasdaq was down 40.56, or 0.79%, to 5,071.62, and the S&P 500 was down 2.18, or 0.1%, to 2,100.13.
11:56 EDTAMDStocks with call strike movement; RIG AMD
Transocean (RIG) November 20 call option implied volatility increased 2% to 43, AMD (AMD) October 3 call option implied volatility decreased 1% to 52 according to IVolatility.
10:09 EDTMUStreet Check: Bearish analysts made right call on Micron ahead of Q3 miss
Subscribe for More Information
10:00 EDTMU, SNXOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: ARM Holdings (ARMH) downgraded to Underperform from Market Perform at Bernstein... Apogee Enterprises (APOG) downgraded to Market Perform from Outperform at Northland... Atlas Resource Partners (ARP) downgraded to Underperform from Neutral at BofA/Merrill... Bank of the Ozarks (OZRK) downgraded to Hold from Buy at Drexel Hamilton... China Cord Blood (CO) downgraded to Neutral from Buy at Roth Capital... Citizens Financial (CFG) downgraded to Neutral from Buy at Guggenheim... Community Health (CYH) downgraded to Market Perform from Outperform at Raymond James... Eagle Bancorp (EGBN) downgraded to Hold from Buy at Sandler O'Neill... Fifth Street Senior (FSFR) downgraded to Neutral from Buy at UBS... FireEye (FEYE) downgraded to Equal Weight from Overweight at Barclays... Insight Enterprises (NSIT) downgraded to Underperform at Raymond James... Micron (MU) downgraded to Neutral from Buy at Mizuho... SYNNEX (SNX) downgraded to Hold from Buy at Needham... Swatch Group (SWGAY) downgraded to Equal Weight from Overweight at Barclays... Target (TGT) downgraded to Market Perform from Outperform at BMO Capital... Zoetis (ZTS) downgraded to Market Perform from Outperform at BMO Capital.
09:36 EDTMUActive equity options trading on open
Subscribe for More Information
09:25 EDTMUMicron tumbles after results, levels to watch
Shares have broken down through multiple levels of support and are trading at new 52-week lows in the pre-market. At the current price of $20.30, support is at $19.20. Resistance is at $20.93.
09:15 EDTMUMicron reiterated as a Sell at Goldman
Goldman reiterated its Sell rating on Micron and lowered its price target to $17 from $19 given continued DRAM margin risk and weak free cash flow. The firm sees further headwinds as DDR4 DRAM ASP premium in servers compresses in 2H and from potential 1H 2016 oversupply from higher output and seasonally slower demand.
09:10 EDTMUOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Finish Line (FINL), up 6.5%... Nike (NKE), up 3.2%. ALSO HIGHER: GigaMedia (GIGM), up 14.6% after agreeing to acquire 70% equity interest in Strawberry Cosmetics. DOWN AFTER EARNINGS: Micron Technology (MU), down 14.8%. ALSO LOWER: Celladon (CLDN), down 42.7% after planning to suspend further R&D of MYDICAR program... Real Goods Solar (RGSE), down 18.4% after raising $5M in a common stock and warrant offering... SanDisk (SNDK), down 3.3% after Micron Technology reports quarterly results... Alder Biopharmaceuticals (ALDR), down 2.6% after 4.49M share Secondary priced at $44.50... Sotherly Hotels (SOHO), down 2% after 3M share Secondary priced at $7.11.
08:16 EDTMUMicron price target lowered to $26 from $32 at Pacific Crest
Subscribe for More Information
07:52 EDTMUMicron thesis remains intact despite near-term headwinds, says Topeka
Topeka said its constructive thesis on Micron is intact despite near-term headwinds. The firm expects accelerating cost improvement in late 2015/early 2016 to drive a gross margin recovery in a stabilizing environment and for a balanced supply-demand situation in both DRAM and NAND. Topeka maintains its Buy rating on shares and lowered its price target to $28 from $35.
07:39 EDTMUMicron weakness a buying opportunity, says Cowen
Subscribe for More Information
07:36 EDTMUMicron price target lowered to $27 from $35 at UBS
UBS lowered its price target on Micron Technology to $27 from $35 following its Q3 results. The firm noted a shortfall in both sales and margins and flat demand in DRAM. UBS said the strategy of focusing on more sustainable Mobile and Server DRAM has yet to reach critical mass and maintained its Buy rating on Micron shares.
07:35 EDTSNX, SNXSYNNEX downgraded to Outperform from Buy at CLSA
Subscribe for More Information
07:30 EDTSNXSYNNEX downgraded to Hold from Buy at Needham
Needham downgraded SYNNEX to Hold citing the mixed Q2 report and disappointing guidance.
07:29 EDTMUMicron price target lowered to $23 from $25 at Nomura
Subscribe for More Information
07:27 EDTSNXSYNNEX pullback a buying opportunity, says Citi
Subscribe for More Information
07:21 EDTSNXSYNNEX operating margins should expand later in year, says Brean Capital
Subscribe for More Information
07:16 EDTMUMicron should be bought aggressively at current levels, says Jefferies
Subscribe for More Information
07:14 EDTMUIntel estimates lowered following Micon report at Jefferies
Subscribe for More Information
07:14 EDTMUMicron outlook still positive, says Stifel
After Micron reported weaker than expected results, Stifel blamed the company's difficulties on a greater than expected shift away from PCs. However, the firm thinks the company's strategy of increasing its exposure to other markets is correct, and it believes that DRAM supply can align with end market demand during the current quarter. Stifel cut its price target on the name to $34 from $41 but keeps a Buy rating on the shares.
<< 1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use